Why This Biotech Plummeted Despite Its 'Best-Case' Study - Investor's Business Daily

As reported by Investor's Business Daily

Abivax stock crashed Monday after several patients developed cancer following a study of its ulcerative colitis treatment.

▸ MARKET SAMACHAR VIEW

NEUTRAL

Read full article on Investor's Business Daily ↗

Market Samachar is a news aggregator. This article was originally published by Investor's Business Daily. Tap the button above to read the full story on their site.

INDIAN Realty startup Propsoch raises USD 2 mn seed funding from investors to expand biz Markets-Economic Times
INDIAN Realty firm Dalcore awards Rs 225 cr contract to BL Gupta Construction for Gurugram housing project Markets-Economic Times
COMPANIES NMDC, Fineotex Chemical among 6 commodities stocks that hit a 52-week highs & rallied up to 89% in a month Stocks-Markets-Economic Times
COMPANIES ET Alpha Wealth Summit: What's next for markets, AI and India's growth story? Stocks-Markets-Economic Times
INDIAN Rupee falls 31 paise to close at 95.67 against US dollar Markets-Economic Times
INDIAN Asia's industrial supercycle is outpacing the West Asia oil shock: Chetan Ahya, Morgan Stanley Markets-Economic Times
INDIAN Merritronix IPO booked 315x on Day 3; GMP signals strong listing gains of 52% mint - markets
GLOBAL Lloyds, Halifax and Bank of Scotland app users report outage BBC News

Why This Biotech Plummeted Despite Its 'Best-Case' Study - Investor's Business Daily

More from Market Samachar